.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Julphar
Harvard Business School
Moodys
Fuji
Johnson and Johnson
Queensland Health
McKesson
McKinsey
Medtronic

Generated: January 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 8-318541

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
NovartisSTARLIXnateglinideTABLET;ORAL021204-001Dec 22, 2000ABRXYesNo➤ Subscribe➤ SubscribeYUSE AS A BLOOD GLUCOSE-LOWERING AGENT
NovartisSTARLIXnateglinideTABLET;ORAL021204-002Dec 22, 2000ABRXYesYes➤ Subscribe➤ SubscribeYUSE AS A BLOOD GLUCOSE-LOWERING AGENT
NovartisSTARLIXnateglinideTABLET;ORAL021204-001Dec 22, 2000ABRXYesNo➤ Subscribe➤ SubscribeYUSE AS A BLOOD GLUCOSE-LOWERING AGENT
NovartisSTARLIXnateglinideTABLET;ORAL021204-002Dec 22, 2000ABRXYesYes➤ Subscribe➤ SubscribeYUSE AS A BLOOD GLUCOSE-LOWERING AGENT
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist